Gregorio Pineda
Neurology · Bakersfield, CANPI 1184603151
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,310 and has fallen 98.0% since, to $65 in 2021.
Across 198 payments — averaging $22.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$512
- Sunovion Pharmaceuticals Inc.$478
- EMD Serono, Inc.$427
- Novartis$354
- Abbott$229
- Acadia Pharmaceuticals Inc$165
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,474100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 15 | $512 |
| Sunovion Pharmaceuticals Inc. | 22 | $478 |
| EMD Serono, Inc. | 14 | $427 |
| Novartis | 19 | $354 |
| Abbott | 6 | $229 |
| Acadia Pharmaceuticals Inc | 9 | $165 |
| AstraZeneca | 8 | $159 |
| Biogen | 7 | $152 |
| Neurelis, Inc. | 7 | $152 |
| UCB, Inc. | 8 | $151 |
| Teva Pharmaceuticals USA, Inc. | 13 | $139 |
| Neurocrine Biosciences, Inc. | 6 | $135 |
| AbbVie(2 entities) | 7 | $131 |
| MDD US Operations, LLC | 4 | $131 |
| Supernus Pharmaceuticals, Inc. | 6 | $129 |
| Akcea Therapeutics, Inc. | 2 | $121 |
| Adamas Pharmaceuticals, Inc. | 5 | $111 |
| Greenwich Biosciences, Inc. | 2 | $94 |
| Merz North America, Inc. | 3 | $87 |
| Sanofi | 4 | $85 |
| Eisai Inc. | 5 | $82 |
| Avanir Pharmaceuticals, Inc. | 5 | $82 |
| SK Life Science, Inc. | 5 | $78 |
| Ipsen Biopharmaceuticals, Inc | 4 | $78 |
| Sarepta Therapeutics, Inc. | 2 | $45 |
| Saol Therapeutics Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $24 |
| Amgen | 1 | $24 |
| Boston Scientific | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mavenclad$224
- Infinity DBS Pulse Generators$136
- APTIOM$125
- VNS Therapy$119
- AFINITOR$110
- TEGSEDI$102
- Rebif$100
How this compares
$4,483 in reported general payments places this provider in the 65th percentile of 1,996 neurology providers in California.
Other neurology in Bakersfield
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
- Parshaw DorrizMission Viejo$1.5M
- Benjamin FrishbergCarlsbad$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.